Latest Regulatory News

Infini Resources Limited has announced a $3.4 million capital raise through a flow-through share offer aimed at advancing exploration at its Portland Creek Uranium Project in Canada. The prospectus highlights significant risks but underscores the company's strategic focus on critical minerals.

Visioneering Technologies Inc. has requested an immediate suspension from ASX trading as it prepares for removal from the official list, raising questions about the company’s future.

Artrya has secured a pivotal three-year commercial contract with Sonic Healthcare Australia to deploy its AI-driven Salix Coronary Anatomy platform across over 125 radiology centres, marking a significant step in commercialising its coronary artery disease diagnostic technology.

Echo IQ has secured a $1.26 million refund under the Australian Government's R&D Tax Incentive, reinforcing its commitment to AI-driven solutions for structural heart disease detection.

South32 has obtained federal environmental approval for its Worsley Mine Development Project, paving the way for sustained bauxite mining and alumina production through at least fiscal year 2036.

Astute Metals NL has announced a significant JORC-compliant Exploration Target for its Red Mountain Lithium Project in Nevada, highlighting substantial lithium potential and outlining aggressive drilling plans for 2025.

Vanadium Resources Limited (ASX: VR8) has been reinstated to trading following a suspension linked to new funding arrangements, signaling renewed operational momentum.

Titanium Sands Limited has raised $500,000 through a placement to advance environmental approvals and mining licence progress for its Mannar Island Heavy Mineral Project in Sri Lanka.

Avenira Limited has ended its licensing agreement with Aleees, freeing the company to focus on a phased development of its Wonarah Phosphate Project aimed at early revenue generation in late 2025.

Beacon Minerals has secured key regulatory approvals to launch multiple drilling programs at its Lady Ida Iguana Project, setting the stage for intensified exploration activity over the coming months.

Estrella Resources has reported exceptional manganese assay results from its Lautém Project in Timor-Leste, revealing grades up to 58.6% Mn and paving the way for imminent drilling activities.

Island Pharmaceuticals has successfully completed patient dosing in the Phase 2b therapeutic arm of its PROTECT clinical trial for ISLA-101, targeting dengue fever treatment. High-level results are expected within two months, potentially advancing a significant antiviral candidate.